<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>24269459</identifier>
<setSpec>1989-7286</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Gómez-Ulla, F</dc:author>
<dc:author>Rodriguez-Cid, M J</dc:author>
<dc:author>García-Ben, A</dc:author>
<dc:description xml:lang="en">CLINICAL CASE We report a case of a 42 year-old male with a macular edema due to idiopathic juxtafoveal retinal telangiectasis type i, treated with 3 sequential injections of intravitreal bevacizumab (1.25 mg in 0.05 ml). Anatomical improvements were observed after one year of follow up. DISCUSSION There is currently no general consensus regarding the treatment of unilateral idiopathic juxtafoveal telangiectasis. The therapeutic options are, grid laser photocoagulation, intravitreal triamcinolone, verteporfin photodynamic therapy, or anti-VEGF. Visual acuity and anatomical improvements were observed in this case after intravitreal bevacizumab. Thus, intravitreal bevacizumab seems to be effective to treat macular edema in idiopathic juxtafoveal telangiectasis type i.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:subject>Anti-factor de crecimiento endotelial vascular</dc:subject>
<dc:subject>Anti-vascular endothelial growth factor</dc:subject>
<dc:subject>Optical coherence tomographic</dc:subject>
<dc:subject>Idiopathic juxtafoveal telangiectasis</dc:subject>
<dc:subject>Macular edema</dc:subject>
<dc:subject>Tomografía óptica de coherencia</dc:subject>
<dc:subject>Edema macular</dc:subject>
<dc:subject>Telangiectasias yuxtafoveales idiopáticas</dc:subject>
<dc:subject>Bevacizumab</dc:subject>
<dc:date>2014 Jul </dc:date>
<dc:title xml:lang="es">Bevacizumab intravítreo como tratamiento de las telangiectasias yuxtafoveales idiopáticas tipo i.</dc:title>
<dc:title xml:lang="en">[Intravitreal bevacizumab in the treatment of idiopathic juxtafoveal telangiectasis type I].</dc:title>
<dc:publisher>Archivos de la Sociedad Espanola de Oftalmologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
